Home > Annual Financials > AMRUTANJAN HEALTH CARE

AMRUTANJAN HEALTH CARE Financial Statement Analysis
[BOM: 590006|NSE : AMRUTANJAN]

The Revenues of AMRUTANJAN HEALTH CARE have increased by 10.96% YoY .
The Earnings Per Share (EPS) of AMRUTANJAN HEALTH CARE has increased by 14.16 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

AMRUTANJAN HEALTH CARE Last 5 Annual Financial Results
[BOM: 590006|NSE : AMRUTANJAN]

StandaloneMar2024
Mar2023
Mar2022
Mar2021
Mar2020
Revenues ₹421 Cr₹380 Cr₹406 Cr₹333 Cr₹261 Cr
Expenses ₹369 Cr₹335 Cr₹328 Cr₹266 Cr₹231 Cr
Operating Profit (Excl OI) ₹52 Cr₹45 Cr₹78 Cr₹67 Cr₹31 Cr
Other Income ₹16 Cr₹15 Cr₹17 Cr₹19 Cr₹8.32 Cr
Interest ₹0.25 Cr₹0.22 Cr₹0.58 Cr₹0.59 Cr₹0.34 Cr
Depreciation ₹6.06 Cr₹5.21 Cr₹3.80 Cr₹3.67 Cr₹4.36 Cr
Profit Before Tax ₹62 Cr₹54 Cr₹91 Cr₹82 Cr₹34 Cr
Profit After Tax ₹45 Cr₹40 Cr₹67 Cr₹61 Cr₹25 Cr
Earnings Per Share (Rs)₹15.56₹13.63₹22.99₹20.93₹8.58
PAT Margin (%)10.6810.4916.5618.389.59
ROE(%)15.5414.3728.0332.6916.44
ROCE(%)21.4719.3837.9344.0022.80
Total Debt/Equity(x)0.000.000.000.000.00

Key Financials

Market Cap : ₹ 2,054.8 Cr
Revenue (TTM) : ₹ 437.7 Cr
Net Profit(TTM) : ₹ 47.5 Cr
EPS (TTM) : ₹ 16.4
P/E (TTM) : 43.2

Industry Peers & Returns1W1M1Y
AMRUTANJAN HEALTH CARE -3% 4% 24.3%
SUN PHARMACEUTICAL INDUSTRIES 1% 0.7% 47.3%
CIPLA 0.3% -1.8% 19.6%
DR REDDYS LABORATORIES 6% 11.8% 20.3%
ZYDUS LIFESCIENCES -1.5% -0.1% 47%
DIVIS LABORATORIES -1.1% -5.8% 61.7%
MANKIND PHARMA 3.7% 11.4% 59.4%
TORRENT PHARMACEUTICALS 0.6% 4.1% 59.5%
LUPIN 3.3% 2.9% 75.9%


AMRUTANJAN HEALTH CARE Revenues
[BOM: 590006|NSE : AMRUTANJAN]

Y-o-Y

10.96 %

5 Yr CAGR

12.66 %

Years Revenues % Change
Mar2024 ₹421 Cr
10.96
Mar2023 ₹380 Cr
-6.46
Mar2022 ₹406 Cr
21.93
Mar2021 ₹333 Cr
27.29
Mar2020 ₹261 Cr -


AMRUTANJAN HEALTH CARE Operating Profit
[BOM: 590006|NSE : AMRUTANJAN]

Y-o-Y

16.54 %

5 Yr CAGR

13.91 %

Years Operating Profit % Change
Mar2024 ₹52 Cr
16.54
Mar2023 ₹45 Cr
-42.56
Mar2022 ₹78 Cr
15.34
Mar2021 ₹67 Cr
118.05
Mar2020 ₹31 Cr -

Operating Margins
Y-o-Y

5.03 %

5 Yr CAGR

1.11 %

Years Operating Margin% % Change
Mar2024 12.32%
5.03
Mar2023 11.73%
-38.62
Mar2022 19.11%
-5.40
Mar2021 20.2%
71.33
Mar2020 11.79% -

AMRUTANJAN HEALTH CARE Profit After Tax
[BOM: 590006|NSE : AMRUTANJAN]

Y-o-Y

12.90 %

5 Yr CAGR

15.72 %

Years Profit After Tax % Change
Mar2024 ₹45 Cr
12.90
Mar2023 ₹40 Cr
-40.71
Mar2022 ₹67 Cr
9.80
Mar2021 ₹61 Cr
143.95
Mar2020 ₹25 Cr -

PAT Margins
Y-o-Y

1.81 %

5 Yr CAGR

2.73 %

Years PAT Margin(%) % Change
Mar2024 10.68 %
1.81
Mar2023 10.49 %
-36.65
Mar2022 16.56 %
-9.90
Mar2021 18.38 %
91.66
Mar2020 9.59 % -

AMRUTANJAN HEALTH CARE Earnings Per Share (EPS)
[BOM: 590006|NSE : AMRUTANJAN]

Y-o-Y

14.16 %

5 Yr CAGR

16.05 %

Years EPS % Change
Mar2024 ₹16
14.16
Mar2023 ₹14
-40.71
Mar2022 ₹23
9.84
Mar2021 ₹21
143.94
Mar2020 ₹8.58 -

AMRUTANJAN HEALTH CARE Return on Capital Employed (ROCE)
[BOM: 590006|NSE : AMRUTANJAN]

Y-o-Y

10.78 %

5 Yr CAGR

-1.49 %

Years ROCE % Change
Mar2024 21.47%
10.78
Mar2023 19.38%
-48.91
Mar2022 37.93%
-13.80
Mar2021 44%
92.98
Mar2020 22.8% -

AMRUTANJAN HEALTH CARE Share Price vs Sensex

Current Share Price : ₹711.0
Current MarketCap: ₹ 2,054.8 Cr
Updated EOD on :Dec 26,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
AMRUTANJAN HEALTH CARE

-3%

4%

24.3%

SENSEX

-2.1%

-2%

11.3%

AMRUTANJAN HEALTH CARE related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about AMRUTANJAN HEALTH CARE Financials


How the annual revenues of AMRUTANJAN HEALTH CARE have changed ?

The Revenues of AMRUTANJAN HEALTH CARE have increased by 10.96% YoY .

How the Earnings per Share (EPS) of AMRUTANJAN HEALTH CARE have changed?

The Earnings Per Share (EPS) of AMRUTANJAN HEALTH CARE has increased by 14.16 % YoY .